These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37856537)

  • 1. Cross-feeding affects the target of resistance evolution to an antifungal drug.
    Durand R; Jalbert-Ross J; Fijarczyk A; Dubé AK; Landry CR
    PLoS Genet; 2023 Oct; 19(10):e1011002. PubMed ID: 37856537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of flucytosine resistance in Candida glabrata.
    Edlind TD; Katiyar SK
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4733-8. PubMed ID: 20823283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
    Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast.
    Paluszynski JP; Klassen R; Meinhardt F
    Microbiology (Reading); 2008 Oct; 154(Pt 10):3154-3164. PubMed ID: 18832321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae.
    Paluszynski JP; Klassen R; Rohe M; Meinhardt F
    Yeast; 2006 Jul; 23(9):707-15. PubMed ID: 16845689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Influencing the Nitrogen-Source Dependent Flucytosine Resistance in Cryptococcus Species.
    Yang DH; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
    mBio; 2023 Feb; 14(1):e0345122. PubMed ID: 36656038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.
    Jacobs SE; Jacobs JL; Dennis EK; Taimur S; Rana M; Patel D; Gitman M; Patel G; Schaefer S; Iyer K; Moon J; Adams V; Lerner P; Walsh TJ; Zhu Y; Anower MR; Vaidya MM; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0005322. PubMed ID: 35770999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris.
    Mayr EM; Ramírez-Zavala B; Krüger I; Morschhäuser J
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32321822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of primary resistance to flucytosine in Candida albicans.
    Hope WW; Tabernero L; Denning DW; Anderson MJ
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4377-86. PubMed ID: 15504867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata.
    Vandeputte P; Pineau L; Larcher G; Noel T; Brèthes D; Chabasse D; Bouchara JP
    Mycopathologia; 2011 Jan; 171(1):11-21. PubMed ID: 20617462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetrical dose responses shape the evolutionary trade-off between antifungal resistance and nutrient use.
    Després PC; Cisneros AF; Alexander EMM; Sonigara R; Gagné-Thivierge C; Dubé AK; Landry CR
    Nat Ecol Evol; 2022 Oct; 6(10):1501-1515. PubMed ID: 36050399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in
    Rybak JM; Muñoz JF; Barker KS; Parker JE; Esquivel BD; Berkow EL; Lockhart SR; Gade L; Palmer GE; White TC; Kelly SL; Cuomo CA; Rogers PD
    mBio; 2020 May; 11(3):. PubMed ID: 32398311
    [No Abstract]   [Full Text] [Related]  

  • 15. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular and biochemical mechanisms of drug resistance in fungi].
    Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):199-208. PubMed ID: 10536306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.
    Noël T; François F; Paumard P; Chastin C; Brèthes D; Villard J
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1275-84. PubMed ID: 12654658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance
    Burrack LS; Todd RT; Soisangwan N; Wiederhold NP; Selmecki A
    mBio; 2022 Aug; 13(4):e0084222. PubMed ID: 35862787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci.
    Chang YC; Lamichhane AK; Cai H; Walter PJ; Bennett JE; Kwon-Chung KJ
    Nat Commun; 2021 Jun; 12(1):3418. PubMed ID: 34103502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
    Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.